CoronaBlog – a Coronavirus Blog from CompBioMed

Welcome to CoronaBlog – a coronavirus blog from CompBioMed that updates you with what’s happening in the fight against coronovirus, using supercomputers.

  • The World’s Fastest Computer to Join Fight Against COVID-19
    The World’s Fastest Computer to Join Fight Against COVID-19
    Nick Laver

    In our previous blog posts we have highlighted in the work of the Argonne National Laboratory (ANL) and Barcelona Supercomputing Center (BSC) that High Performance Computing (HPC) resources are an invaluable research tool. Much like their counterparts and colleagues around the world, Japan’s top scientists are now refocusing and accelerating their research efforts towards addressing…Read More+

    Read More »
  • AI-driven integrative biology for accelerating therapeutic drug discoveries to treat SARS-CoV-2
    AI-driven integrative biology for accelerating therapeutic drug discoveries to treat SARS-CoV-2
    Nick Laver

    CompBioMed partners and academics from other research facilities are carrying out research to address the fundamental biological mechanisms of both the SARS-CoV-2 novel corona virus and the COVID-19 disease it causes. The ongoing research also includes an attempt to target the entire viral proteome (entire complement of proteins that is or can be expressed by…Read More+

    Read More »
  • Cardiotoxicity: Supercomputer-based in silico studies by CompBioMed Core Partners aiming to make COVID-19 treatment safer for the heart
    Cardiotoxicity: Supercomputer-based in silico studies by CompBioMed Core Partners aiming to make COVID-19 treatment safer for the heart
    Nick Laver

    The use of certain drugs can disturb the rhythm at which hearts beat.  This disruption can have toxic effects on the heart, which are particularly dangerous for those with underlying medical conditions.  Two drugs which are known to have proarrhythmic effects are the antimalarial drugs azithromycin and hydroxychloroquine. Azithromycin and hydroxychloroquine are thought to be…Read More+

    Read More »
  • Repurposing Existing Drugs in the Fight Against COVID-19
    Repurposing Existing Drugs in the Fight Against COVID-19
    Nick Laver

    The use of existing pharmaceutical to treat COVID-19 has several potential benefits over the development of new drugs from the group up, not least that much shorter clinical trials would be needed and production on industrial scales has already been realised in many cases. Andrew Potterton, a PhD student at UCL and Evotec, described to…Read More+

    Read More »
  • Coronavirus Resources Across CompBioMed
    Coronavirus Resources Across CompBioMed
    Nick Laver

    Here at CoronaBlog, where we will be providing regular news and updates on the research activities of the CompBioMed members, their collaborators, and the wider scientific community, we have established several other resources to provide information and aid in the COVID-19 research efforts: CompBioMed and Coronavirus provides an overview of the current CompBioMed activities, highlighting the…Read More+

    Read More »